-
81
A computational chemistry-based approach to optimizing PD-1/PD-L1 inhibitors
Published 2025-01-01Subjects: Get full text
Article -
82
-
83
Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis
Published 2025-01-01Subjects: “…PD-L1…”
Get full text
Article -
84
A facile one-step electrochemical preparation of graphene–Pd nanocomposite as a catalyst for hydrogen evolution reaction
Published 2023-07-01Subjects: Get full text
Article -
85
Overcoming immune evasion with innovative multi-target approaches for glioblastoma
Published 2025-01-01Subjects: Get full text
Article -
86
-
87
Design and Study of a Novel P-Type Junctionless FET for High Performance of CMOS Inverter
Published 2025-01-01Subjects: “…PD-SOI…”
Get full text
Article -
88
The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
Published 2025-01-01Subjects: Get full text
Article -
89
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles
Published 2025-12-01Subjects: Get full text
Article -
90
-
91
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
92
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion
Published 2025-01-01Subjects: Get full text
Article -
93
Targeted Delivery of BMS-1166 for Enhanced Breast Cancer Immunotherapy
Published 2025-01-01Subjects: “…pd-l1…”
Get full text
Article -
94
Radiomics-based biomarker for PD-1 status and prognosis analysis in patients with HCC
Published 2025-01-01Subjects: Get full text
Article -
95
Recurrent NTM pulmonary disease despite avoidance of hot spring exposure in a plaque psoriasis patient treated with Secukinumab: a case report
Published 2025-01-01Subjects: Get full text
Article -
96
Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma
Published 2025-01-01Subjects: “…melanoma, anti-PD-1, anti-LAG-3, adverse events…”
Get full text
Article -
97
Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment
Published 2025-01-01Subjects: Get full text
Article -
98
Prognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinoma
Published 2025-02-01Subjects: “…PD-L1…”
Get full text
Article -
99
Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
Published 2025-01-01Subjects: Get full text
Article -
100